|
|
Volumn 24, Issue 3, 2003, Pages 221-222
|
|
Use of antiparkinsonian drugs in the Umbria region
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 HYDROXYTRYPTOPHAN;
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
ANTIPARKINSON AGENT;
APOMORPHINE;
ATYPICAL ANTIPSYCHOTIC AGENT;
BROMOCRIPTINE;
CITALOPRAM;
CLOMIPRAMINE;
DESIPRAMINE;
DOPAMINE RECEPTOR BLOCKING AGENT;
DOSULEPIN;
FLUOXETINE;
FLUVOXAMINE;
IMIPRAMINE;
MAPROTILINE;
MIANSERIN;
MIRTAZAPINE;
NEFAZODONE;
NORTRIPTYLINE;
PAROXETINE;
PERGOLIDE;
PRAMIPEXOLE;
ROPINIROLE;
SELEGILINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRAZODONE;
TRIMIPRAMINE;
UNINDEXED DRUG;
ARTICLE;
CLINICAL PRACTICE;
DATA BASE;
DRUG USE;
FINANCIAL MANAGEMENT;
HUMAN;
ITALY;
PARKINSONISM;
POPULATION RESEARCH;
PRACTICE GUIDELINE;
PRESCRIPTION;
TIME MANAGEMENT;
AGED;
AGED, 80 AND OVER;
ANTIPARKINSON AGENTS;
DATABASE MANAGEMENT SYSTEMS;
DRUG THERAPY, COMBINATION;
DRUG UTILIZATION;
EPIDEMIOLOGIC STUDIES;
FEMALE;
HUMANS;
ITALY;
MALE;
MIDDLE AGED;
PARKINSON DISEASE;
|
|
EID: 0142217522
PISSN: 15901874
EISSN: None
Source Type: Journal
DOI: 10.1007/s10072-003-0140-0 Document Type: Article |
|
Times cited : (7)
|
|
References (6)
|
